Tag: moderna
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a…
Read More
Moderna set to start final-stage trial of its coronavirus vaccine by July
Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus that causes COVID-19 by July. Moderna was the first company to begin human clinical trials of its vaccine candidate in the U.S., and the last stage…
Read More
University of Oxford coronavirus vaccine trial aims to have 500 people in testing by mid-May
One of the largest COVID-19 vaccine trials currently underway will have over 500 volunteers actively testing its solution by the middle of next month. Researchers at the University of Oxford have already secured that number of participants, including a representative sample of people between the ages of 18 to 55,…
Read More
A second potential COVID-19 vaccine, backed by Bill and Melinda Gates, is entering human testing
A new COVID-19 vaccine candidate is entering Phase 1 clinical human testing today, after the U.S. Food and Drug Administration (FDA) accepted an application from Inovio Pharmaceuticals under the regulator’s Investigational New Drug program. Inovio plans to inject its first volunteer test subject with the INO-4800 DNA vaccine candidate it…
Read More
Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech
Flagship Pioneering, the Boston-based biotech company incubator and holding company, said it has raised $1.1 billion for its Flagship Labs unit. Flagship, which raised $1 billion back in 2019 for growth stage investment vehicles, develops and operates startups that leverage biotechnology innovation to provide goods and services that improve human…
Read More
Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall
There are some hard limits to the vaccine development process that mean we are not going to see any preventative immune therapies to fight the new coronavirus for at least a year to 18 months. But Moderna, which is behind the first potential vaccine to enter human clinical trials in…
Read More